ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Dexcel-Pharma Laboratories Limited

Dexcel-Pharma Laboratories Limited is an active company incorporated on 19 December 2006 with the registered office located in Daventry, Northamptonshire. Dexcel-Pharma Laboratories Limited was registered 18 years ago.
Status
Active
Active since incorporation
Company No
06033065
Private limited company
Age
18 years
Incorporated 19 December 2006
Size
Unreported
Confirmation
Submitted
Dated 5 September 2025 (1 day ago)
Next confirmation dated 5 September 2026
Due by 19 September 2026 (1 year remaining)
Last change occurred 8 years ago
Accounts
Submitted
For period 1 Jul ⟶ 30 Jun 2024 (1 year)
Accounts type is Group
Next accounts for period 31 December 2025
Due by 30 September 2026 (1 year remaining)
Learn more about Dexcel-Pharma Laboratories Limited
Contact
Address
7 Sopwith Way
Drayton Fields Industrial Estate
Daventry
NN11 8PB
England
Same address for the past 8 years
Telephone
01283820845
Email
Unreported
Website
Dexcel.com
See All Contacts
People
Officers
3
Shareholders
1
Controllers (PSC)
1
Mr Andrew John Ridsdale
Director • Managing Director • British • Lives in UK • Born in Mar 1971
Mr Anastasis Konstantinou
Director • Cypriot • Lives in Cyprus • Born in Jul 1984
Mr Yigal Seelenfreund
Director • VP International Sales & Marketing • Israeli • Lives in Israel • Born in Aug 1967
Dexcel PT Israel Ltd
PSC
See Key People
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
See All Shareholders, PSCs & Group Structure
Mutual Companies
Dexcel-Pharma Limited
Mr Anastasis Konstantinou, Mr Andrew John Ridsdale, and 1 more are mutual people.
Active
See All Mutual Companies
Financials
Net Assets, Total Assets & Total Liabilities (2014–2024)
Period Ended
30 Jun 2024
For period 30 Jun ⟶ 30 Jun 2024
Traded for 12 months
Cash in Bank
£2.47M
Decreased by £792K (-24%)
Turnover
£21.55M
Decreased by £6.04M (-22%)
Employees
22
Increased by 1 (+5%)
Total Assets
£36.03M
Increased by £6.93M (+24%)
Total Liabilities
-£6.3M
Decreased by £160K (-2%)
Net Assets
£29.73M
Increased by £7.09M (+31%)
Debt Ratio (%)
17%
Decreased by 4.71% (-21%)
See 10 Year Full Financials
Latest Activity
Confirmation Submitted
1 Day Ago on 5 Sep 2025
Group Accounts Submitted
5 Months Ago on 28 Mar 2025
Confirmation Submitted
11 Months Ago on 12 Sep 2024
Group Accounts Submitted
1 Year 2 Months Ago on 28 Jun 2024
Accounting Period Extended
1 Year 11 Months Ago on 14 Sep 2023
Confirmation Submitted
2 Years Ago on 5 Sep 2023
Confirmation Submitted
2 Years 8 Months Ago on 28 Dec 2022
Group Accounts Submitted
2 Years 11 Months Ago on 30 Sep 2022
Mr Yigal Seelenfreund Appointed
3 Years Ago on 23 May 2022
Terry Kenneth Grigg Resigned
3 Years Ago on 23 May 2022
Get Alerts
Get Credit Report
Discover Dexcel-Pharma Laboratories Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
See All Credit Score & Limits
Documents
Confirmation statement made on 5 September 2025 with no updates
Submitted on 5 Sep 2025
Change of accounting reference date
Submitted on 19 Jun 2025
Group of companies' accounts made up to 30 June 2024
Submitted on 28 Mar 2025
Confirmation statement made on 5 September 2024 with no updates
Submitted on 12 Sep 2024
Group of companies' accounts made up to 30 June 2023
Submitted on 28 Jun 2024
Previous accounting period extended from 31 December 2022 to 30 June 2023
Submitted on 14 Sep 2023
Confirmation statement made on 5 September 2023 with no updates
Submitted on 5 Sep 2023
Confirmation statement made on 17 December 2022 with no updates
Submitted on 28 Dec 2022
Group of companies' accounts made up to 31 December 2021
Submitted on 30 Sep 2022
Appointment of Mr Yigal Seelenfreund as a director on 23 May 2022
Submitted on 25 May 2022
Explore All Documents
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
See All Charges & CCJs